This article is more than 5 years old. Information may no longer be current.

Dana-Farber Cancer Institute names pediatric oncology department chair

Issue: May 25, 2016

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Scott A. Armstrong, MD, PhD, has been named chair of the department of pediatric oncology at Dana-Farber Cancer Institute.

Scott A. Armstrong

Armstrong also will serve as David G. Nathan professor of pediatrics at Dana-Farber Cancer Institute, Boston Children’s Hospital and Harvard Medical School, as well as associate chief of the division of hematology and oncology at Boston Children’s Hospital.

Armstrong previously served as director of the Center for Epigenetics Research, vice chair of pediatrics and member of the cancer biology and genetics program at Memorial Sloan Kettering Cancer Center. He also served as professor of pediatrics at Weill Cornell Medical College.

“In addition to his exceptional research and clinical credentials, Scott is a proven able program leader,” Edward J. Benz, Jr., MD, president and CEO of Dana-Farber Cancer Institute, said in a press release. “Throughout his career, Scott has been universally admired and respected for his vision, collegiality and integrity, as well as for his clinical and research achievements.”